Published in Biotech Business Week, October 20th, 2008
Although the risk of being diagnosed with cancer increases with age, relatively few older patients participate in clinical trials. There is a general perception that older patients derive less benefit from therapy and are more likely to suffer side effects than younger patients, despite increasing evidence that there is little or no difference between these patients groups as long as the older patients have good organ function.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.